157 related articles for article (PubMed ID: 17972276)
21. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
[TBL] [Abstract][Full Text] [Related]
22. Nabilone produces marked impairments to cognitive function and changes in subjective state in healthy volunteers.
Wesnes KA; Annas P; Edgar CJ; Deeprose C; Karlsten R; Philipp A; Kalliomäki J; Segerdahl M
J Psychopharmacol; 2010 Nov; 24(11):1659-69. PubMed ID: 19525335
[TBL] [Abstract][Full Text] [Related]
23. The acute nootropic effects of Ginkgo biloba in healthy older human subjects: a preliminary investigation.
Nathan PJ; Ricketts E; Wesnes K; Mrazek L; Greville W; Stough C
Hum Psychopharmacol; 2002 Jan; 17(1):45-9. PubMed ID: 12404706
[TBL] [Abstract][Full Text] [Related]
24. Effects of zinc supplementation on cognitive function in healthy middle-aged and older adults: the ZENITH study.
Maylor EA; Simpson EE; Secker DL; Meunier N; Andriollo-Sanchez M; Polito A; Stewart-Knox B; McConville C; O'Connor JM; Coudray C
Br J Nutr; 2006 Oct; 96(4):752-60. PubMed ID: 17010236
[TBL] [Abstract][Full Text] [Related]
25. Selective effects of clonidine and temazepam on attention and memory.
Tiplady B; Bowness E; Stien L; Drummond G
J Psychopharmacol; 2005 May; 19(3):259-65. PubMed ID: 15888511
[TBL] [Abstract][Full Text] [Related]
26. Effects of Panax ginseng, consumed with and without glucose, on blood glucose levels and cognitive performance during sustained 'mentally demanding' tasks.
Reay JL; Kennedy DO; Scholey AB
J Psychopharmacol; 2006 Nov; 20(6):771-81. PubMed ID: 16401645
[TBL] [Abstract][Full Text] [Related]
27. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
[TBL] [Abstract][Full Text] [Related]
28. Examining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: 90 day double-blind placebo-controlled randomized trial.
Stough C; Downey LA; Lloyd J; Silber B; Redman S; Hutchison C; Wesnes K; Nathan PJ
Phytother Res; 2008 Dec; 22(12):1629-34. PubMed ID: 18683852
[TBL] [Abstract][Full Text] [Related]
29. Creatine supplementation does not improve cognitive function in young adults.
Rawson ES; Lieberman HR; Walsh TM; Zuber SM; Harhart JM; Matthews TC
Physiol Behav; 2008 Sep; 95(1-2):130-4. PubMed ID: 18579168
[TBL] [Abstract][Full Text] [Related]
30. Cerebral metabolic effects of intravenous glycine in healthy human subjects.
Neumeister A; Carson R; Henry S; Planeta-Wilson B; Binneman B; Maguire RP; Luckenbaugh DA; D'Souza C; Krystal JH; Frost JJ
J Clin Psychopharmacol; 2006 Dec; 26(6):595-9. PubMed ID: 17110816
[TBL] [Abstract][Full Text] [Related]
31. High-dose glycine inhibits the loudness dependence of the auditory evoked potential (LDAEP) in healthy humans.
O'Neill BV; Croft RJ; Leung S; Oliver C; Phan KL; Nathan PJ
Psychopharmacology (Berl); 2007 Nov; 195(1):85-93. PubMed ID: 17646968
[TBL] [Abstract][Full Text] [Related]
32. Memory functions and focussed attention in middle-aged and elderly subjects are unaffected by a low, acute dose of caffeine.
Schmitt JA; Hogervorst E; Vuurman EF; Jolles J; Riedel WJ
J Nutr Health Aging; 2003; 7(5):301-3. PubMed ID: 12917744
[TBL] [Abstract][Full Text] [Related]
33. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.
Otmani S; Demazières A; Staner C; Jacob N; Nir T; Zisapel N; Staner L
Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235
[TBL] [Abstract][Full Text] [Related]
34. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder.
Potter AS; Newhouse PA
Pharmacol Biochem Behav; 2008 Feb; 88(4):407-17. PubMed ID: 18022679
[TBL] [Abstract][Full Text] [Related]
35. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
Indlekofer F; Piechatzek M; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
[TBL] [Abstract][Full Text] [Related]
36. Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia.
Yang CR; Svensson KA
Pharmacol Ther; 2008 Dec; 120(3):317-32. PubMed ID: 18805436
[TBL] [Abstract][Full Text] [Related]
37. Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone.
Boyle J; Trick L; Johnsen S; Roach J; Rubens R
Hum Psychopharmacol; 2008 Jul; 23(5):385-97. PubMed ID: 18350566
[TBL] [Abstract][Full Text] [Related]
38. The effects of nicotine on cognition are dependent on baseline performance.
Niemegeers P; Dumont GJ; Quisenaerts C; Morrens M; Boonzaier J; Fransen E; de Bruijn ER; Hulstijn W; Sabbe BG
Eur Neuropsychopharmacol; 2014 Jul; 24(7):1015-23. PubMed ID: 24766971
[TBL] [Abstract][Full Text] [Related]
39. Estradiol treatment and its interaction with the cholinergic system: effects on cognitive function in healthy young women.
Bartholomeusz CF; Wesnes KA; Kulkarni J; Vitetta L; Croft RJ; Nathan PJ
Horm Behav; 2008 Nov; 54(5):684-93. PubMed ID: 18706905
[TBL] [Abstract][Full Text] [Related]
40. Cognitive effects of creatine ethyl ester supplementation.
Ling J; Kritikos M; Tiplady B
Behav Pharmacol; 2009 Dec; 20(8):673-9. PubMed ID: 19773644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
